BioXcel Therapeutics
BTAI
BTAI
34 hedge funds and large institutions have $6.04M invested in BioXcel Therapeutics in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
4.49% more ownership
Funds ownership: 10.21% → 14.7% (+4.5%)
0% more funds holding
Funds holding: 34 → 34 (0)
Holders
34
Holding in Top 10
–
Calls
$10K
Puts
$5K
Top Buyers
| 1 | +$2.63M | |
| 2 | +$508K | |
| 3 | +$444K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$248K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$230K |
Top Sellers
| 1 | -$146K | |
| 2 | -$34.1K | |
| 3 | -$20.6K | |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
-$1.82K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.54K |
